Cargando…

Tau pathology reduction with SM07883, a novel, potent, and selective oral DYRK1A inhibitor: A potential therapeutic for Alzheimer's disease

Dual‐specificity tyrosine phosphorylation‐regulated kinase‐1A (DYRK1A) is known to phosphorylate the microtubule‐associated tau protein. Overexpression is correlated with tau hyperphosphorylation and neurofibrillary tangle (NFT) formation in Alzheimer's disease (AD). This study assessed the pot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Melchior, Benoît, Mittapalli, Gopi Kumar, Lai, Carolyn, Duong‐Polk, Karen, Stewart, Joshua, Güner, Bora, Hofilena, Brian, Tjitro, Amanda, Anderson, Scott D., Herman, David S., Dellamary, Luis, Swearingen, Christopher J., Sunil, K.C., Yazici, Yusuf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718548/ https://www.ncbi.nlm.nih.gov/pubmed/31267651 http://dx.doi.org/10.1111/acel.13000

Ejemplares similares

SM04755, a small‐molecule inhibitor of the Wnt pathway, as a potential topical treatment for tendinopathy
por: Deshmukh, Vishal, et al.
Publicado: (2020)

Higgs to tau tau (SM) (HCP)
por: CMS Collaboration
Publicado: (2012)

SM and MSSM $H\rightarrow\tau\tau$
por: Schwindt, Thomas
Publicado: (2014)

SM and MSSM Higgs $\rightarrow\tau\tau$
por: Schwindt, T
Publicado: (2014)

Higgs to tau tau in ATLAS (SM+BSM)
por: Tanasijczuk, A
Publicado: (2013)

DYRK1A antagonists rescue degeneration and behavioural deficits of in vivo models based on amyloid-β, Tau and DYRK1A neurotoxicity
por: Zhu, Bangfu, et al.
Publicado: (2022)

Tau at CMS (From Tau Lepton and Tau in SM measurements to Tau Role in Discovery)
por: Mohammadi, Abdollah
Publicado: (2012)

Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1A
por: Qian, Wei, et al.
Publicado: (2011)

Abemaciclib is a potent inhibitor of DYRK1A and HIP kinases involved in transcriptional regulation
por: Kaltheuner, Ines H., et al.
Publicado: (2021)

HiggsHunting2016 - SM $H\rightarrow\tau^{+}\tau^{-}$ searches with ATLAS
por: Drechsler, Eric
Publicado: (2016)

Selectivity Profiling and Biological Activity of Novel β-Carbolines as Potent and Selective DYRK1 Kinase Inhibitors
por: Rüben, Katharina, et al.
Publicado: (2015)

Mutational analysis of two residues in the DYRK homology box of the protein kinase DYRK1A
por: Widowati, Esti Wahyu, et al.
Publicado: (2018)

DCAF7/WDR68 is required for normal levels of DYRK1A and DYRK1B
por: Yousefelahiyeh, Mina, et al.
Publicado: (2018)

Differential maturation and chaperone dependence of the paralogous protein kinases DYRK1A and DYRK1B
por: Papenfuss, Marco, et al.
Publicado: (2022)

Evidence of the SM Higgs Boson in the Decay Channel into Tau Leptons
por: Manzoni, Riccardo Andrea
Publicado: (2014)

Inhibiting EGFR/HER-2 ameliorates neuroinflammatory responses and the early stage of tau pathology through DYRK1A
por: Kim, Jieun, et al.
Publicado: (2022)

Emerging roles of DYRK2 in cancer
por: Tandon, Vasudha, et al.
Publicado: (2021)

Implications of the ATLAS and CMS searches in the channel $pp \to Higgs \to \tau^+\tau^-$ for the MSSM and SM Higgs bosons
por: Baglio, Julien, et al.
Publicado: (2011)

β-Carboline Compounds, Including Harmine, Inhibit DYRK1A and Tau Phosphorylation at Multiple Alzheimer's Disease-Related Sites
por: Frost, Danielle, et al.
Publicado: (2011)

Disruption of DYRK1A-induced hyperphosphorylation of amyloid-beta and tau protein in Alzheimer’s disease: An integrative molecular modeling approach
por: Shukla, Rohit, et al.
Publicado: (2023)

SM tests in rare B decays with tau leptons in the final state
por: Mancinelli, Giampiero
Publicado: (2018)

Tau Leptons: A tool for studying SM and BSM physics at CMS
por: Manzoni, Riccardo
Publicado: (2017)

The Omnipresence of DYRK1A in Human Diseases
por: Deboever, Estelle, et al.
Publicado: (2022)

Lomerizine inhibits LPS-mediated neuroinflammation and tau hyperphosphorylation by modulating NLRP3, DYRK1A, and GSK3α/β
por: Park, Jin-Hee, et al.
Publicado: (2023)

FRTX-02, a selective and potent inhibitor of DYRK1A, modulates inflammatory pathways in mouse models of psoriasis and atopic dermatitis
por: Kim, Soochan, et al.
Publicado: (2022)

Search the SM Higgs Boson to $bb$, $\tau \tau$, $WW$, $ZZ$ with 4.7 fb$^{-1}$ of CMS Data
por: Bianchini, Lorenzo
Publicado: (2012)

Dyrk1A overexpression leads to increase of 3R-tau expression and cognitive deficits in Ts65Dn Down syndrome mice
por: Yin, Xiaomin, et al.
Publicado: (2017)

Protein phosphatase PPM1B inhibits DYRK1A kinase through dephosphorylation of pS258 and reduces toxic tau aggregation
por: Lee, Ye Hyung, et al.
Publicado: (2021)

Mirk/dyrk1B Kinase in Ovarian Cancer
por: Friedman, Eileen
Publicado: (2013)

Ocular Phenotype Associated with DYRK1A Variants
por: Méjécase, Cécile, et al.
Publicado: (2021)

Discovery and Characterization of Selective and Ligand-Efficient DYRK Inhibitors
por: Henderson, Scott H., et al.
Publicado: (2021)

Functional Roles of DYRK2 as a Tumor Regulator
por: Mochimaru, Yuta, et al.
Publicado: (2023)

A novel de novo heterozygous DYRK1A mutation causes complete loss of DYRK1A function and developmental delay
por: Lee, Kyu-Sun, et al.
Publicado: (2020)

Identification of Suppressors of mbk-2/DYRK by Whole-Genome Sequencing
por: Wang, Yuemeng, et al.
Publicado: (2013)

Clinical phenotype of ASD-associated DYRK1A haploinsufficiency
por: Earl, Rachel K., et al.
Publicado: (2017)

Emerging Roles of DYRK Kinases in Embryogenesis and Hedgehog Pathway Control
por: Singh, Rajeev, et al.
Publicado: (2017)

Dyrk1 inhibition improves Alzheimer's disease‐like pathology
por: Branca, Caterina, et al.
Publicado: (2017)

The DYRK Family of Kinases in Cancer: Molecular Functions and Therapeutic Opportunities
por: Boni, Jacopo, et al.
Publicado: (2020)

Observation of the SM scalar boson decaying to a pair of $\tau$ leptons with the CMS experiment at the LHC
por: CMS Collaboration
Publicado: (2017)

A Search For Associated Production Of A SM Higgs Decaying Into Tau Leptons With The ATLAS Experiment
por: Thomsen, L A
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_p17qinc73gkjl8iedsd243v42g